4th Annual Precision Genomics Midwest - 10.8.2021

Friday, October 8, 2021, 8:55 AM - 3:30 PM, Zoom


Now in its fourth year, PGM has grown into the Midwest’s major genomics conference, attracting attendees from more than 20 states!

1. Describe how precision medicine and genomics can be applied to specific communities or specialties to better understand disease or improve outcomes.
2. Assess how genomics can be best used in a clinical setting to improve patient care.
3. Identify resources to use genomics in diagnosis and treatment.

PGM features sessions on:

• Cardiac Genomics
• Ethical, Legal & Social Implications
• Genetics of Time
• Implementation of Clinical Genomics
• Microbiome
• Pharmacogenomics

Registration:

There is not a fee to attend this conference, however, REGISTRATION IS REQUIRED.

 In support of improving patient care, Cincinnati Children’s Hospital Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CME:This activity has been approved for 5.25 AMA PRA Category 1 Credit™.

Nursing: This activity is approved for 5.25 continuing nursing education (CNE)  contact hours.

Pharmacy: This activity is approved for 5.25 pharmacy contact hours.

This activity was planned by and for the healthcare team, and learners will receive Interprofessional Continuing Education (IPCE) credits for learning and change.

AMA PRA Category 1 Credits™ (5.25 hours), CME - Non-Physician (Attendance) (5.25 hours), IPCE (5.25 hours), Nursing CE (5.25 hours), Pharmacy (5.25 hours)

Mitigation of Relevant Financial Relationships

Cincinnati Childrens Hospital Medical Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Friday, October 8, 2021